--- title: "Kaleido Biosciences, Inc. (KLDO.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/KLDO.US/norm.md" symbol: "KLDO.US" name: "Kaleido Biosciences, Inc." parent: "https://longbridge.com/en/quote/KLDO.US.md" datetime: "2026-03-12T10:52:39.265Z" locales: - [en](https://longbridge.com/en/quote/KLDO.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/KLDO.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/KLDO.US/norm.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/KLDO.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/KLDO.US/norm.md) # Kaleido Biosciences, Inc. (KLDO.US) — Financial Reports ## Income Statement (USD) | Indicator | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | | --- | --- | --- | --- | --- | --- | | EPS | -0.4759 | -0.5422 | -0.5616 | -0.5805 | -0.5563 | | ROE | -407.41% | -232.40% | -156.60% | -199.78% | -283.93% | | Revenue | 492000.00 | 104000.00 | 211000.00 | 297000.00 | 243000.00 | | Net income | -20.27M | -23.09M | -23.89M | -23.04M | -20.02M | | Operating income | -19.55M | -22.41M | -23.21M | -22.35M | -19.49M | | Gross margin | -3065.45% | -16641.35% | -8256.87% | -5686.20% | -5800.41% | | Net margin | -4120.33% | -22197.12% | -11321.80% | -7758.25% | -8237.04% | | Profit quality | - | - | - | - | - | ## Balance Sheet (USD) | Indicator | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | | --- | --- | --- | --- | --- | --- | | A&L | 50.14M | 67.80M | 84.29M | 105.03M | 59.34M | | Leverage | 4.73 | 2.32 | 1.68 | 1.46 | 2.90 | | BVPS | 0.2490 | 0.6858 | 1.18 | 1.69 | 0.5690 | | Turnover | 0.0202 | 0.0121 | 0.0144 | 0.0148 | 0.0138 | | Cash & STI | 38.47M | 55.66M | 71.98M | 92.36M | 46.22M | | Inv & Rec | - | - | - | - | - | | LT assets | 5.67M | 7.34M | 7.53M | 7.83M | 8.46M | | Net debt | -16.78M | -34.14M | -50.63M | -71.17M | -25.21M | ## Cash Flow Statement (USD) | Indicator | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | | --- | --- | --- | --- | --- | --- | | Operating CF | -17.16M | -15.88M | -20.08M | -23.97M | -11.30M | | Investing CF | 2000.00 | -431000.00 | -232000.00 | -30000.00 | -662000.00 | | Financing CF | -25000.00 | -14000.00 | -68000.00 | 70.14M | 3.65M | | Free CF | -10.88M | -7.56M | -11.24M | -15.27M | -2.81M | | OCF coverage | -3935.78% | -3683.76% | -8656.47% | -79913.33% | -1706.50% | | Repaid & issued | - | - | - | - | - | | CapEx | -436000.00 | -431000.00 | -232000.00 | -30000.00 | -662000.00 |